⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockSwitzerlandNYSE

ADCT

ADC Therapeutics SA

Healthcare · Drug Manufacturers - Specialty & Generic

1.44USD

-0.1600 (-10.00%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on ADCT.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 1.44
P/E—
Dvd Ind Yld0.0%
P/B—
P/S2.2
Curr EV/T12M EBITDA-4.3
Mkt Cap (USD)0.2B
Curr EV (USD)0.4B
2)

Per Share Data

EPS T12M-0.67
DPS—
Bk Val Per Sh-1.79
Rev/Sh0.55
Cash/Sh1.72
Curr Shares Out127.7M
FCF/Sh-0.66
3)

Cash Flow Analysis

P/CF-1.8
Curr P/FCF-1.8
CF/NI1.1
Dvd P/O—
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales-121.0%
Eff Interest Rate845.7%
4)

Growth Potential

Dil EPS 1Y Gr30.9%
Cap 1Y Gr9.8%
BPS 1Y Gr29.9%
R&D To Sales97.3%
Retention Rate—
Rev 1Y Gr14.9%
FCF 1Y Gr-13.4%
Assets 1Y Gr0.4%
5)

Profitability

EBITDA-0.1B
EBIT-0.1B
Operating Margin-117.8%
Pretax Margin-115.1%
Net Margin-114.6%
ROA-32.3%
ROE45.3%
ROC-47.2%
Asset Turnover0.28
6)

Structure

Current Ratio3.03
Quick Ratio2.86
Debt/Assets156.8%
Debt/Com Eq-192.0%
Net Debt/EBITDA-1.81
Tot Debt/Capital208.7%
Gross Margin89.4%
EBIT/Int Exp-1.9

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.